Overview

Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambia

Status:
Terminated

Trial end date:
2016-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the tolerability and safety of increasing doses of primaquine in combination with dihydroartemisinin-piperaquine in G6PD deficient males.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

London School of Hygiene and Tropical Medicine

Collaborator:

Medical Research Council Unit, The Gambia

Treatments:

Artemisinins
Artenimol
Dihydroartemisinin
Piperaquine
Primaquine